Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Approved
Current status date:
2023-04-06
Product name:
TAGAMET PREVENT
DIN:
02238161
Product Monograph/Veterinary Labelling:
Date:
2023-03-22
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
MEDTECH PRODUCTS INC
660 White Plains Road
Tarrytown
New York
United States
10591
Class:
Human
Dosage form(s):
Tablet
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
56:28.12
Anatomical Therapeutic Chemical (ATC): See footnote 4
A02BA01 CIMETIDINE
Active ingredient group (AIG) number:See footnote5
0111925005
| Active ingredient(s) | Strength |
|---|---|
| CIMETIDINE | 200 MG |